GeneDx Holdings Corp. (WGS)
90.27
+2.86
(+3.28%)
USD |
NASDAQ |
Aug 26, 16:00
91.31
+1.04
(+1.15%)
After-Hours: 19:41
GeneDx Holdings Shareholders Equity (Quarterly) : 244.22M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 244.22M |
| March 31, 2026 | 254.12M |
| December 31, 2025 | 308.18M |
| September 30, 2025 | 292.26M |
| June 30, 2025 | 277.13M |
| March 31, 2025 | 257.40M |
| December 31, 2024 | 245.25M |
| September 30, 2024 | 204.50M |
| June 30, 2024 | 194.04M |
| March 31, 2024 | 207.22M |
| December 31, 2023 | 228.02M |
| September 30, 2023 | 254.26M |
| Date | Value |
|---|---|
| June 30, 2023 | 296.11M |
| March 31, 2023 | 328.47M |
| December 31, 2022 | 253.70M |
| September 30, 2022 | 561.29M |
| June 30, 2022 | 637.27M |
| March 31, 2022 | 329.44M |
| December 31, 2021 | 388.10M |
| September 30, 2021 | 391.26M |
| June 30, 2021 | 312.76M |
| March 31, 2021 | 299.75M |
| December 31, 2020 | 4.388M |
| September 30, 2020 | 428.68M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CS Diagnostics Corp. | 499.47M |
| Aibotics, Inc. | -4.602M |
| GRAIL, Inc. | 2.543B |
| Ayujoy Herbals Ltd. | -- |
| Twist Bioscience Corp. | 445.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 481.49M |
| Total Liabilities (Quarterly) | 237.26M |
| Debt to Equity Ratio | 0.6855 |
| Current Ratio | 3.301 |
| Net Debt Paydown Yield | -0.50% |